Clinical Trial Update: Adrenocorticotropic Hormone in Membranous Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating adrenocorticotropic hormone in membranous nephropathy has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Adrenocorticotropic Hormone (adrenocorticotropic hormone)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Membranous Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2022-08-15